| Patents for A61P 25 - Drugs for disorders of the nervous system (183,225) |
|---|
| 02/18/2009 | CN101366804A Medicament composition for preventing birth defect and improving memory |
| 02/18/2009 | CN101366803A Medicament composition for preventing birth defect and improving memory |
| 02/18/2009 | CN101366802A Medicament composition for preventing birth defect and improving memory |
| 02/18/2009 | CN101366801A Medicament composition for preventing birth defect and improving memory |
| 02/18/2009 | CN101366800A Medicament composition for preventing birth defect and improving memory |
| 02/18/2009 | CN101366799A Medicament composition for preventing birth defect and improving memory |
| 02/18/2009 | CN101366798A Medicament composition for preventing birth defect and improving memory |
| 02/18/2009 | CN101366797A Medicament composition for preventing birth defect and improving memory |
| 02/18/2009 | CN101366796A Medicament composition for preventing birth defect and improving memory |
| 02/18/2009 | CN101366795A Medicament composition for preventing birth defect and improving memory |
| 02/18/2009 | CN101366794A Medicament composition for preventing birth defect and improving memory |
| 02/18/2009 | CN101366793A Medicament composition for preventing birth defect and improving memory |
| 02/18/2009 | CN101366792A Medicament composition for preventing birth defect and improving memory |
| 02/18/2009 | CN101366791A Medicament composition for preventing birth defect and improving memory |
| 02/18/2009 | CN101366789A Medicament composition for preventing birth defect and improving memory |
| 02/18/2009 | CN101366788A Medicament composition for preventing birth defect and improving memory |
| 02/18/2009 | CN101366786A Medicament composition for preventing birth defection and improving memory |
| 02/18/2009 | CN101366785A Medicament composition for preventing birth defection and improving memory |
| 02/18/2009 | CN101366784A Medicament composition for preventing birth defection and improving memory |
| 02/18/2009 | CN101366783A Medicament composition for preventing birth defection and improving memory |
| 02/18/2009 | CN101366782A Medicament composition for preventing birth defection and improving memory |
| 02/18/2009 | CN101366781A Medicament composition for preventing birth defection and improving memory |
| 02/18/2009 | CN101366780A Pharmaceutical combination for preventing birth defect and improving anamnesis |
| 02/18/2009 | CN101366779A Medicament composition for preventing birth defection and improving memory |
| 02/18/2009 | CN101366778A Medicament composition for preventing birth defection and improving memory |
| 02/18/2009 | CN101366777A Medicament composition for preventing birth defection and improving memory |
| 02/18/2009 | CN101366776A Medicament composition for preventing birth defection and improving memory |
| 02/18/2009 | CN101366775A Medicament composition for preventing birth defection and improving memory |
| 02/18/2009 | CN101366774A Medicament composition for preventing birth defection and improving memory |
| 02/18/2009 | CN101366773A Medicament composition for preventing birth defection and improving memory |
| 02/18/2009 | CN101366772A Medicament composition for preventing birth defection and improving memory |
| 02/18/2009 | CN101366771A Medicament composition for preventing birth defect and improving memory |
| 02/18/2009 | CN101366770A Uses of composition of epimedium brevicornum total flavone and notoginsen triterpenes |
| 02/18/2009 | CN101366768A Pharmaceutical combination for preventing birth defect and improving anamnesis |
| 02/18/2009 | CN101366767A Pharmaceutical combination for preventing birth defect and improving anamnesis |
| 02/18/2009 | CN101366766A Pharmaceutical combination for preventing birth defect and improving anamnesis |
| 02/18/2009 | CN101366765A Pharmaceutical combination for preventing birth defect and improving anamnesis |
| 02/18/2009 | CN101366764A Pharmaceutical combination for preventing birth defect and improving anamnesis |
| 02/18/2009 | CN101366763A Pharmaceutical combination for preventing birth defect and improving anamnesis |
| 02/18/2009 | CN101366762A Pharmaceutical combination for preventing birth defect and improving anamnesis |
| 02/18/2009 | CN101366761A Pharmaceutical combination for preventing birth defect and improving anamnesis |
| 02/18/2009 | CN101366760A Pharmaceutical combination for preventing birth defect and improving anamnesis |
| 02/18/2009 | CN101366759A Pharmaceutical combination for preventing birth defect and improving anamnesis |
| 02/18/2009 | CN101366758A Pharmaceutical combination for preventing birth defect and improving anamnesis |
| 02/18/2009 | CN101366757A Pharmaceutical combination for preventing birth defect and improving anamnesis |
| 02/18/2009 | CN101366756A Pharmaceutical combination for preventing birth defect and improving anamnesis |
| 02/18/2009 | CN101366755A Pharmaceutical combination for preventing birth defect and improving anamnesis |
| 02/18/2009 | CN101366754A Pharmaceutical combination for preventing birth defect and improving anamnesis |
| 02/18/2009 | CN101366753A Pharmaceutical combination for preventing birth defect and improving anamnesis |
| 02/18/2009 | CN101366752A Medicament composition for preventing birth defect and improving memory and intelligence |
| 02/18/2009 | CN101366751A Medicament composition for preventing birth defect and improving memory and intelligence |
| 02/18/2009 | CN101366750A Medicament composition for preventing birth defect and improving memory |
| 02/18/2009 | CN101366749A Pharmaceutical combination for preventing birth defect and improving anamnesis |
| 02/18/2009 | CN101366748A Pharmaceutical combination for preventing birth defect and improving anamnesis |
| 02/18/2009 | CN101366747A Pharmaceutical combination for preventing birth defect and improving anamnesis |
| 02/18/2009 | CN101366746A Pharmaceutical combination for preventing birth defect and improving anamnesis |
| 02/18/2009 | CN101366745A Pharmaceutical combination for preventing birth defect and improving anamnesis |
| 02/18/2009 | CN101366744A Pharmaceutical combination for preventing birth defect and improving anamnesis |
| 02/18/2009 | CN101366743A Pharmaceutical combination for preventing birth defect and improving anamnesis |
| 02/18/2009 | CN101366742A Medicament composition for preventing birth defect and improving memory |
| 02/18/2009 | CN101366741A Medicament composition for preventing birth defect and improving memory |
| 02/18/2009 | CN101366740A Medicament composition for preventing birth defect and improving memory |
| 02/18/2009 | CN101366732A Preparation of full-natural centipede dry powder |
| 02/18/2009 | CN101366720A Pharmaceutical uses of polyene phosphatidyl choline for treating cognitive impairment |
| 02/18/2009 | CN101366714A Acetylene derivatives having mGluR5 antagonistic activity |
| 02/18/2009 | CN101366709A Application of turmeric native |
| 02/18/2009 | CN101366708A Application of alpha-ararin in preparing anxiolytic and antidepressant medicament |
| 02/18/2009 | CN101366705A Risperidone percutaneous absorption paster |
| 02/18/2009 | CN101366588A Health care massage pillow |
| 02/18/2009 | CN101366528A Medicament composition for preventing birth defect and improving memory |
| 02/18/2009 | CN101366527A Medicament composition for preventing birth defect and improving memory |
| 02/18/2009 | CN101366526A Medicament composition for preventing birth defection and improving memory |
| 02/18/2009 | CN101366423A Natural tea for protecting liver, relieving or neutralizing the effect of alcohol |
| 02/18/2009 | CN100462363C Heteroaryl-substituted imdazole derivatives as glutamate receptor antagonists |
| 02/18/2009 | CN100462359C 5-sulfanyl-4H-1,2,4-triazole derivatives and their use as a medicament |
| 02/18/2009 | CN100462351C Amino acids with affinity for the alpha-2-delta-protein |
| 02/18/2009 | CN100462095C Brain and intellectual health care medicine and its preparation |
| 02/18/2009 | CN100462069C Valproic acid derivatives for the treatment of pain. |
| 02/17/2009 | US7491835 Prodrugs of amino acids with affinity for the α2δ-protein |
| 02/17/2009 | US7491825 e.g. N-[2-[4-(2-(S)-amino-6-dimethylamino-hexanoyl)-piperazin-1-yl]-1,1-dimethyl-2-oxo-ethyl]-2,4-dichloro-3-(2-methyl -quinolin-8-yloxy-methyl)-benzensulfonamide trifluoroacetate; antiinflammatory agent; asthma, chronic bronchitis, allergic rhinitis, obstructive pulmonary disease (COPD) |
| 02/17/2009 | US7491796 Retro-inversion peptides that target GIT receptors and related methods |
| 02/17/2009 | US7491741 Diaminopropionic acid derivatives |
| 02/17/2009 | US7491740 Isoxazoline compounds having MIF antagonist activity |
| 02/17/2009 | US7491734 psychotic and intellectual impairment disorders; Alzheimer's disease, cognitive or attention disorders, antidepressant, anxiolytic agent; ,smoking cessation, neuroprotection, schizophrenia, analgesia, Tourette's syndrome, and Parkinson's disease |
| 02/17/2009 | US7491733 Bicyclic guanidine derivatives and therapeutic uses thereof |
| 02/17/2009 | US7491730 Compositions useful as inhibitors of GSK-3 |
| 02/17/2009 | US7491729 3-Substituted 3,4-dihydro-thieno[2,3-d]pyrimidin-4-one derivatives, production and use thereof |
| 02/17/2009 | US7491717 1-(3,4-dibromo-benzyl)-2-[4-(1-methyl-piperidin-4-yl)-piperazin-1-yl]-2-oxo-ethyl 4-(2-oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl)-piperidine-1-carboxylate; calcitonin gene related peptide antagonist; analgesic, antidiabetic agent; migraine or cluster headaches, non-insulin-dependent diabetes |
| 02/17/2009 | US7491716 Glycogen synthase kinase-3 inhibitors such as [1-(4-Imidazo[1,2-a]pyridin-3-yl-2,5-dioxo-2,5-dihydro-1H-pyrrol-3-yl)-6,7-dihydro-6H-[1,4]diazepino[6,7,1-hi]indol-6-yl]-[morpholin-4-yl]methylenecyanamide, used for treating diabetes, Alzheimer's disease and for stimulating bone deposition in mammals |
| 02/17/2009 | US7491715 Analogs of clozapine; use with other neuropsychiatric agents; depression, anxiety, bipolar disorder, psychoses secondary to Alzheimer's or Huntington's disease |
| 02/17/2009 | US7491713 ligands for Calcitonin gene related peptide; azepinone ligands; migranes; N-[5-(2,3-Difluorophenyl)-1-(2-methoxyethyl)-2-oxopiperidin-3-yl]-4-(2-oxo-2,3-dihydro-1H-imidazo[4,5-b]pyridin-1-yl)piperidine-1-carboxamide |
| 02/17/2009 | US7491677 Composite sample on support; concentration gradients |
| 02/17/2009 | US7491550 Diagnostics and therapeutics for diseases associated with Neuromedin U2 receptor (NMU2) |
| 02/17/2009 | US7491516 Dual specificity antibodies and methods of making and using |
| 02/17/2009 | US7491410 Food grade transglutaminase inhibitor and uses thereof |
| 02/17/2009 | US7491406 Fast dissolving orally consumable films |
| 02/17/2009 | US7491392 An isolated IL-1 beta binding molecule comprising a heavy chain variable domain; treatment of an IL-1 mediated disease or disorder, e.g. osteoarthritis, osteroporosis and other inflammatory arthritis |
| 02/17/2009 | US7491047 Delivery of antihistamines through an inhalation route |
| 02/17/2009 | CA2445189C Carboline derivatives as pdev inhibitors |
| 02/17/2009 | CA2400217C Pteridine compounds for the treatment of psoriasis |